Please enter your username and password below, if you are not yet a member of Oncology Central remember you can register for free.
Already have an account? Login here
Balkees Abderrahman, M.D. is 2020 Forbes Magazine 30 Under 30 in science, the Dallas/Ft. Worth Living Legend Fellow of Cancer Research at the Department of Breast Medical Oncology, the University of Texas MD Anderson Cancer Center (TX, USA) and a PhD trainee under model “Individuals of Very High Quality” at the Faculty of Biological Sciences, the University of Leeds (West Yorkshire, UK). Author of “Hormones and Cancer, Oxford Textbook of Cancer Biology 2018”, “First Targeted Therapy — History of Tamoxifen, Estrogen Receptor and Breast Cancer, Cancer Drug Discovery and Development, Springer Nature 2018”, “Selective Estrogen Receptor Modulators (SERMs), Estrogen Receptor and Breast Cancer, Cancer Drug Discovery and Development, Springer Nature 2018”, “Steroid Receptors in Breast Cancer, The Breast: Comprehensive Management of Benign and Malignant Diseases 2017”, “Love at the Gate”, and “Oliver and the Rock”. Key organizer and advocate at the UK Royal Society of Medicine (London, UK). Contributor at “Science”, “Nature”, “JAMA Oncology”, “ASCO Post”, “The Pharmaceutical Journal of UK Royal Pharmaceutical Society”, “The Hill”, “The Huffington Post”, “US News and World Report”, “The Nation”, and “The Independent”. A Finalist for the Outstanding Youth Award at the United Nations from over 86 countries for “Her outstanding work in tackling some of our greatest social, economic, and environmental challenges”. To learn more about Balkees, visit her Linkedin page or follow her on twitter @Balkees_Abd
Recent articles from Balkees: